The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Aclaris Therapeutics Inc (ACRS) COM 00461U105 616,926 434,455 SH SOLE 434,455 0 0
Bicara Therapeutics Inc. (BCAX) COM 055477103 5,285,258 568,919 SH SOLE 568,919 0 0
Biomea Fusion Inc (BMEA) COM 09077A106 3,687,763 2,048,757 SH SOLE 2,048,757 0 0
BridgeBio Pharma Inc. (BBIO) COM 10806X102 262,021,638 6,068,125 SH SOLE 6,068,125 0 0
CalciMedica, Inc. (CALC) COM NEW 38942Q202 833,782 521,114 SH SOLE 521,114 0 0
Compass Pathways Plc (CMPS) SPONSORED ADS 20451W101 3,355,570 1,198,418 SH SOLE 1,198,418 0 0
Elevation Oncology Inc (ELEV) COM 28623U101 1,040,695 2,834,910 SH SOLE 2,834,910 0 0
Marker Therapeutics, Inc. (MRKR) COM NEW 57055L206 497,816 325,370 SH SOLE 325,370 0 0
Monte Rosa Therapeutics Inc (GLUE) COM 61225M102 6,640,213 1,472,331 SH SOLE 1,472,331 0 0
Nuvation Bio Inc. (NUVB) COM CL A 67080N101 4,954,968 2,541,009 SH SOLE 2,541,009 0 0
OnKure Therapeutics, Inc. (OKUR) COM CL A 68277Q105 211,771 88,607 SH SOLE 88,607 0 0
Syndax Pharmaceuticals, Inc. (SNDX) COM 87164F105 12,325,304 1,316,806 SH SOLE 1,316,806 0 0
Verona Pharma plc (VRNA) SPONSORED ADS 925050106 58,199,992 615,352 SH SOLE 615,352 0 0